Seattle Genetics Inc. reported a net loss of $6.9 million for the second quarter of 2013, which was an improvement from the $17.2 million loss reported for the same period in 2012.
Revenues for the second quarter of 2013 were $73.6 million, up significantly from $48.8 million for the same period last year.
As of June 30, 2013, Seattle Genetics had $338.1 million in cash, cash equivalents and investments, compared to $330.3 million at the same time last year.
Revenues in 2013 included Adcetris…
Seattle Genetics Inc. reported a net loss of $6.9 million for the second quarter of 2013, which was an improvement from the $17.2 million loss reported for the same period in 2012.
Revenues for the second quarter of 2013 were $73.6 million, up significantly from $48.8 million for the same period last year.
As of June 30, 2013, Seattle Genetics had $338.1 million in cash, cash equivalents and investments, compared to $330.3 million at the same time last year.
Revenues in 2013 included Adcetris…